Mildly elevated serum bilirubin and its correlations with lipid levels among male patients undergoing health checkups

Background Bilirubin's ability to lower lipid levels was confirmed by several studies, but those studies mainly focused on total bilirubin (TBil). The present study aimed to elucidate the correlations of the two subtypes of bilirubin with lipid levels. Methods A total of 1732 male patients unde...

Full description

Saved in:
Bibliographic Details
Published inLipids in health and disease Vol. 22; no. 1; pp. 1 - 8
Main Authors Bai, Xin, Qiao, Jing, Zhang, Hong
Format Journal Article
LanguageEnglish
Published London BioMed Central Ltd 04.12.2023
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Bilirubin's ability to lower lipid levels was confirmed by several studies, but those studies mainly focused on total bilirubin (TBil). The present study aimed to elucidate the correlations of the two subtypes of bilirubin with lipid levels. Methods A total of 1732 male patients undergoing health checkups were categorized into three groups according to the levels of direct bilirubin (DBil) and indirect bilirubin (IBil). The differences in medical characteristics among the three groups were analysed. Results Subjects in the elevated DBil group had the lowest serum alanine aminotransferase (ALT), total cholesterol (TC), blood urea nitrogen (BUN), [gamma]-glutamyl transpeptidase ([gamma]-GT), fasting blood glucose (FBG), haemoglobin (HGB), and triglyceride (TG) levels in contrast to the other groups (P < 0.01), while subjects in the elevated IBil group had the highest ALT, [gamma]-GT, BUN, serum creatinine (SCR), HGB, TC, and TG levels among the three groups (P < 0.01). DBil levels exhibited a significant negative correlation with TC (r = -0.777, P < 0.01) and TG (r = -0.397, P < 0.01) levels, while IBil levels exhibited a significant positive correlation with TC (r = 0.790, P < 0.01) and TG (r = 0.302, P < 0.01) levels. The frequencies of abnormal TC, TG, HGB and BUN levels were the lowest in the elevated DBil group, while the levels of these four variables were the highest in the elevated IBil group. Mildly elevated DBil levels were related to lower TG (OR = 0.112, 95% CI = 0.027-0.458) and TC (OR = 0.097, 95% CI = 0.013-0.700), and mildly elevated IBil levels were connected with increased TC (OR = 3.436, 95% CI = 2.398-4.924) and TG (OR = 1.636, 95% CI = 1.163-2.303). DBil was an independent protective factor against increased TC (OR = 0.702, 95% CI = 0.602-0.817, P < 0.01) and TG (OR = 0.632, 95% CI = 0.541-0.739, P < 0.01) levels, and IBil was an independent risk factors for increased TC (OR = 1.251, 95% CI = 1.176-1.331, P < 0.01). Conclusions DBil was an independent protective factor against high TC and TG levels. IBil was an independent risk factors for elevated TC levels. The prognostic value of IBil levels warrants further attention. Keywords: Direct bilirubin (DBil), Triglyceride (TG), Indirect bilirubin (IBil), Total cholesterol (TC), Total bilirubin (TBil)
AbstractList Background Bilirubin's ability to lower lipid levels was confirmed by several studies, but those studies mainly focused on total bilirubin (TBil). The present study aimed to elucidate the correlations of the two subtypes of bilirubin with lipid levels. Methods A total of 1732 male patients undergoing health checkups were categorized into three groups according to the levels of direct bilirubin (DBil) and indirect bilirubin (IBil). The differences in medical characteristics among the three groups were analysed. Results Subjects in the elevated DBil group had the lowest serum alanine aminotransferase (ALT), total cholesterol (TC), blood urea nitrogen (BUN), [gamma]-glutamyl transpeptidase ([gamma]-GT), fasting blood glucose (FBG), haemoglobin (HGB), and triglyceride (TG) levels in contrast to the other groups (P < 0.01), while subjects in the elevated IBil group had the highest ALT, [gamma]-GT, BUN, serum creatinine (SCR), HGB, TC, and TG levels among the three groups (P < 0.01). DBil levels exhibited a significant negative correlation with TC (r = -0.777, P < 0.01) and TG (r = -0.397, P < 0.01) levels, while IBil levels exhibited a significant positive correlation with TC (r = 0.790, P < 0.01) and TG (r = 0.302, P < 0.01) levels. The frequencies of abnormal TC, TG, HGB and BUN levels were the lowest in the elevated DBil group, while the levels of these four variables were the highest in the elevated IBil group. Mildly elevated DBil levels were related to lower TG (OR = 0.112, 95% CI = 0.027-0.458) and TC (OR = 0.097, 95% CI = 0.013-0.700), and mildly elevated IBil levels were connected with increased TC (OR = 3.436, 95% CI = 2.398-4.924) and TG (OR = 1.636, 95% CI = 1.163-2.303). DBil was an independent protective factor against increased TC (OR = 0.702, 95% CI = 0.602-0.817, P < 0.01) and TG (OR = 0.632, 95% CI = 0.541-0.739, P < 0.01) levels, and IBil was an independent risk factors for increased TC (OR = 1.251, 95% CI = 1.176-1.331, P < 0.01). Conclusions DBil was an independent protective factor against high TC and TG levels. IBil was an independent risk factors for elevated TC levels. The prognostic value of IBil levels warrants further attention. Keywords: Direct bilirubin (DBil), Triglyceride (TG), Indirect bilirubin (IBil), Total cholesterol (TC), Total bilirubin (TBil)
Abstract Background Bilirubin’s ability to lower lipid levels was confirmed by several studies, but those studies mainly focused on total bilirubin (TBil). The present study aimed to elucidate the correlations of the two subtypes of bilirubin with lipid levels. Methods A total of 1732 male patients undergoing health checkups were categorized into three groups according to the levels of direct bilirubin (DBil) and indirect bilirubin (IBil). The differences in medical characteristics among the three groups were analysed. Results Subjects in the elevated DBil group had the lowest serum alanine aminotransferase (ALT), total cholesterol (TC), blood urea nitrogen (BUN), γ-glutamyl transpeptidase (γ-GT), fasting blood glucose (FBG), haemoglobin (HGB), and triglyceride (TG) levels in contrast to the other groups (P < 0.01), while subjects in the elevated IBil group had the highest ALT, γ-GT, BUN, serum creatinine (SCR), HGB, TC, and TG levels among the three groups (P < 0.01). DBil levels exhibited a significant negative correlation with TC (r = -0.777, P < 0.01) and TG (r = -0.397, P < 0.01) levels, while IBil levels exhibited a significant positive correlation with TC (r = 0.790, P < 0.01) and TG (r = 0.302, P < 0.01) levels. The frequencies of abnormal TC, TG, HGB and BUN levels were the lowest in the elevated DBil group, while the levels of these four variables were the highest in the elevated IBil group. Mildly elevated DBil levels were related to lower TG (OR = 0.112, 95% CI = 0.027–0.458) and TC (OR = 0.097, 95% CI = 0.013–0.700), and mildly elevated IBil levels were connected with increased TC (OR = 3.436, 95% CI = 2.398–4.924) and TG (OR = 1.636, 95% CI = 1.163–2.303). DBil was an independent protective factor against increased TC (OR = 0.702, 95% CI = 0.602–0.817, P < 0.01) and TG (OR = 0.632, 95% CI = 0.541–0.739, P < 0.01) levels, and IBil was an independent risk factors for increased TC (OR = 1.251, 95% CI = 1.176–1.331, P < 0.01). Conclusions DBil was an independent protective factor against high TC and TG levels. IBil was an independent risk factors for elevated TC levels. The prognostic value of IBil levels warrants further attention.
BackgroundBilirubin’s ability to lower lipid levels was confirmed by several studies, but those studies mainly focused on total bilirubin (TBil). The present study aimed to elucidate the correlations of the two subtypes of bilirubin with lipid levels.MethodsA total of 1732 male patients undergoing health checkups were categorized into three groups according to the levels of direct bilirubin (DBil) and indirect bilirubin (IBil). The differences in medical characteristics among the three groups were analysed.ResultsSubjects in the elevated DBil group had the lowest serum alanine aminotransferase (ALT), total cholesterol (TC), blood urea nitrogen (BUN), γ-glutamyl transpeptidase (γ-GT), fasting blood glucose (FBG), haemoglobin (HGB), and triglyceride (TG) levels in contrast to the other groups (P < 0.01), while subjects in the elevated IBil group had the highest ALT, γ-GT, BUN, serum creatinine (SCR), HGB, TC, and TG levels among the three groups (P < 0.01). DBil levels exhibited a significant negative correlation with TC (r = -0.777,P < 0.01) and TG (r = -0.397,P < 0.01) levels, while IBil levels exhibited a significant positive correlation with TC (r = 0.790,P < 0.01) and TG (r = 0.302,P < 0.01) levels. The frequencies of abnormal TC, TG, HGB and BUN levels were the lowest in the elevated DBil group, while the levels of these four variables were the highest in the elevated IBil group. Mildly elevated DBil levels were related to lower TG (OR = 0.112, 95% CI = 0.027–0.458) and TC (OR = 0.097, 95% CI = 0.013–0.700), and mildly elevated IBil levels were connected with increased TC (OR = 3.436, 95% CI = 2.398–4.924) and TG (OR = 1.636, 95% CI = 1.163–2.303). DBil was an independent protective factor against increased TC (OR = 0.702, 95% CI = 0.602–0.817, P < 0.01) and TG (OR = 0.632, 95% CI = 0.541–0.739, P < 0.01) levels, and IBil was an independent risk factors for increased TC (OR = 1.251, 95% CI = 1.176–1.331, P < 0.01).ConclusionsDBil was an independent protective factor against high TC and TG levels. IBil was an independent risk factors for elevated TC levels. The prognostic value of IBil levels warrants further attention.
Bilirubin's ability to lower lipid levels was confirmed by several studies, but those studies mainly focused on total bilirubin (TBil). The present study aimed to elucidate the correlations of the two subtypes of bilirubin with lipid levels.BACKGROUNDBilirubin's ability to lower lipid levels was confirmed by several studies, but those studies mainly focused on total bilirubin (TBil). The present study aimed to elucidate the correlations of the two subtypes of bilirubin with lipid levels.A total of 1732 male patients undergoing health checkups were categorized into three groups according to the levels of direct bilirubin (DBil) and indirect bilirubin (IBil). The differences in medical characteristics among the three groups were analysed.METHODSA total of 1732 male patients undergoing health checkups were categorized into three groups according to the levels of direct bilirubin (DBil) and indirect bilirubin (IBil). The differences in medical characteristics among the three groups were analysed.Subjects in the elevated DBil group had the lowest serum alanine aminotransferase (ALT), total cholesterol (TC), blood urea nitrogen (BUN), γ-glutamyl transpeptidase (γ-GT), fasting blood glucose (FBG), haemoglobin (HGB), and triglyceride (TG) levels in contrast to the other groups (P < 0.01), while subjects in the elevated IBil group had the highest ALT, γ-GT, BUN, serum creatinine (SCR), HGB, TC, and TG levels among the three groups (P < 0.01). DBil levels exhibited a significant negative correlation with TC (r = -0.777, P < 0.01) and TG (r = -0.397, P < 0.01) levels, while IBil levels exhibited a significant positive correlation with TC (r = 0.790, P < 0.01) and TG (r = 0.302, P < 0.01) levels. The frequencies of abnormal TC, TG, HGB and BUN levels were the lowest in the elevated DBil group, while the levels of these four variables were the highest in the elevated IBil group. Mildly elevated DBil levels were related to lower TG (OR = 0.112, 95% CI = 0.027-0.458) and TC (OR = 0.097, 95% CI = 0.013-0.700), and mildly elevated IBil levels were connected with increased TC (OR = 3.436, 95% CI = 2.398-4.924) and TG (OR = 1.636, 95% CI = 1.163-2.303). DBil was an independent protective factor against increased TC (OR = 0.702, 95% CI = 0.602-0.817, P < 0.01) and TG (OR = 0.632, 95% CI = 0.541-0.739, P < 0.01) levels, and IBil was an independent risk factors for increased TC (OR = 1.251, 95% CI = 1.176-1.331, P < 0.01).RESULTSSubjects in the elevated DBil group had the lowest serum alanine aminotransferase (ALT), total cholesterol (TC), blood urea nitrogen (BUN), γ-glutamyl transpeptidase (γ-GT), fasting blood glucose (FBG), haemoglobin (HGB), and triglyceride (TG) levels in contrast to the other groups (P < 0.01), while subjects in the elevated IBil group had the highest ALT, γ-GT, BUN, serum creatinine (SCR), HGB, TC, and TG levels among the three groups (P < 0.01). DBil levels exhibited a significant negative correlation with TC (r = -0.777, P < 0.01) and TG (r = -0.397, P < 0.01) levels, while IBil levels exhibited a significant positive correlation with TC (r = 0.790, P < 0.01) and TG (r = 0.302, P < 0.01) levels. The frequencies of abnormal TC, TG, HGB and BUN levels were the lowest in the elevated DBil group, while the levels of these four variables were the highest in the elevated IBil group. Mildly elevated DBil levels were related to lower TG (OR = 0.112, 95% CI = 0.027-0.458) and TC (OR = 0.097, 95% CI = 0.013-0.700), and mildly elevated IBil levels were connected with increased TC (OR = 3.436, 95% CI = 2.398-4.924) and TG (OR = 1.636, 95% CI = 1.163-2.303). DBil was an independent protective factor against increased TC (OR = 0.702, 95% CI = 0.602-0.817, P < 0.01) and TG (OR = 0.632, 95% CI = 0.541-0.739, P < 0.01) levels, and IBil was an independent risk factors for increased TC (OR = 1.251, 95% CI = 1.176-1.331, P < 0.01).DBil was an independent protective factor against high TC and TG levels. IBil was an independent risk factors for elevated TC levels. The prognostic value of IBil levels warrants further attention.CONCLUSIONSDBil was an independent protective factor against high TC and TG levels. IBil was an independent risk factors for elevated TC levels. The prognostic value of IBil levels warrants further attention.
Bilirubin's ability to lower lipid levels was confirmed by several studies, but those studies mainly focused on total bilirubin (TBil). The present study aimed to elucidate the correlations of the two subtypes of bilirubin with lipid levels. A total of 1732 male patients undergoing health checkups were categorized into three groups according to the levels of direct bilirubin (DBil) and indirect bilirubin (IBil). The differences in medical characteristics among the three groups were analysed. Subjects in the elevated DBil group had the lowest serum alanine aminotransferase (ALT), total cholesterol (TC), blood urea nitrogen (BUN), [gamma]-glutamyl transpeptidase ([gamma]-GT), fasting blood glucose (FBG), haemoglobin (HGB), and triglyceride (TG) levels in contrast to the other groups (P < 0.01), while subjects in the elevated IBil group had the highest ALT, [gamma]-GT, BUN, serum creatinine (SCR), HGB, TC, and TG levels among the three groups (P < 0.01). DBil levels exhibited a significant negative correlation with TC (r = -0.777, P < 0.01) and TG (r = -0.397, P < 0.01) levels, while IBil levels exhibited a significant positive correlation with TC (r = 0.790, P < 0.01) and TG (r = 0.302, P < 0.01) levels. The frequencies of abnormal TC, TG, HGB and BUN levels were the lowest in the elevated DBil group, while the levels of these four variables were the highest in the elevated IBil group. Mildly elevated DBil levels were related to lower TG (OR = 0.112, 95% CI = 0.027-0.458) and TC (OR = 0.097, 95% CI = 0.013-0.700), and mildly elevated IBil levels were connected with increased TC (OR = 3.436, 95% CI = 2.398-4.924) and TG (OR = 1.636, 95% CI = 1.163-2.303). DBil was an independent protective factor against increased TC (OR = 0.702, 95% CI = 0.602-0.817, P < 0.01) and TG (OR = 0.632, 95% CI = 0.541-0.739, P < 0.01) levels, and IBil was an independent risk factors for increased TC (OR = 1.251, 95% CI = 1.176-1.331, P < 0.01). DBil was an independent protective factor against high TC and TG levels. IBil was an independent risk factors for elevated TC levels. The prognostic value of IBil levels warrants further attention.
ArticleNumber 213
Audience Academic
Author Zhang, Hong
Bai, Xin
Qiao, Jing
Author_xml – sequence: 1
  givenname: Xin
  surname: Bai
  fullname: Bai, Xin
– sequence: 2
  givenname: Jing
  surname: Qiao
  fullname: Qiao, Jing
– sequence: 3
  givenname: Hong
  surname: Zhang
  fullname: Zhang, Hong
BookMark eNptUk1r3DAQNSWFJmn_QE-CXnpxog9btk4lhKYJpPTSQm9CH2OvtrLkSnaW_Ptqs6HtliIYDTPvvWGGd1adhBigqt4SfEFIzy8zoaJpakxZjYnoRL17UZ2SpuN1S8j3k7_yV9VZzluMKe44P63Wz85b_4jAw4NawKIMaZ2Qdt6lVbuAVLDILRmZmBJ4tbgYMtq5ZYO8m51FhQc-IzXFMKJJeUBzAUEolDVYSGN0pbEB5QvFbMD8WOf8uno5KJ_hzfN_Xn27-fj1-ra-__Lp7vrqvjaNoEs9GMwFbQdBG6xoa0AP2gxKcNYIYqlhVBPda2pKELgjqmWgDWGKWeBcWXZe3R10bVRbOSc3qfQoo3LyqRDTKFVanPEgle01EKo5L4ccVKPbDlpgvbFG88ayovXhoDWvegJryopJ-SPR405wGznGB0nKEo1o9wrvnxVS_LlCXuTksgHvVYC4Zkl70TPCMG0L9N0_0G1cUyi3klRgSliJ_A9qLHeXLgyxDDZ7UXnVdW3TEcH2Yy_-gyrPwuRM8dHgSv2IQA8Ek2LOCYbfSxIs93aTB7vJYjf5ZDe5Y78AFvLNFg
Cites_doi 10.1042/CS20120661
10.1016/S0021-9150(01)00601-3
10.1016/0304-4165(93)90013-X
10.1152/ajpgi.2000.279.2.G356
10.1152/physiolgenomics.00028.2019
10.1186/s13098-021-00762-0
10.3109/10641963.2015.1060990
10.3389/fendo.2021.792795
10.1371/journal.pone.0193041
10.1186/s12933-022-01484-x
10.1186/s12883-021-02398-z
10.1016/j.atherosclerosis.2017.12.021
10.1016/j.atherosclerosis.2014.05.927
10.1016/j.plipres.2023.101235
10.1111/j.1753-0407.2011.00138.x
10.1152/ajpendo.00405.2020
10.1016/j.bbadis.2021.166079
10.1016/j.atherosclerosis.2014.12.053
10.1373/clinchem.2010.151043
10.1038/pr.2015.247
10.1161/01.ATV.8.4.368
10.1016/j.atherosclerosis.2020.12.005
10.1016/j.ajpc.2021.100149
10.1016/j.clinbiochem.2014.08.014
10.1186/s12944-018-0857-7
10.18632/aging.100004
10.1126/science.1204265
10.3390/ijms17122093
10.1007/s11745-010-3408-1
10.1016/j.jhep.2021.06.010
10.1016/j.molmed.2023.01.007
10.1016/j.numecd.2011.03.001
10.1016/0005-2760(88)90235-4
ContentType Journal Article
Copyright COPYRIGHT 2023 BioMed Central Ltd.
2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2023. The Author(s).
The Author(s) 2023
Copyright_xml – notice: COPYRIGHT 2023 BioMed Central Ltd.
– notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2023. The Author(s).
– notice: The Author(s) 2023
DBID AAYXX
CITATION
3V.
7X7
7XB
88E
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
RC3
7X8
5PM
DOA
DOI 10.1186/s12944-023-01979-w
DatabaseName CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Biological Science Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

Publicly Available Content Database
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1476-511X
EndPage 8
ExternalDocumentID oai_doaj_org_article_ad8be12b66944fa4b57e5e38cdcb64d3
PMC10694953
A775471933
10_1186_s12944_023_01979_w
GeographicLocations China
United States--US
Chicago Illinois
GeographicLocations_xml – name: China
– name: United States--US
– name: Chicago Illinois
GroupedDBID ---
0R~
29L
2WC
53G
5GY
5VS
7X7
88E
8FE
8FH
8FI
8FJ
A8Z
AAFWJ
AAHBH
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BHPHI
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IGS
IHR
INH
INR
ITC
KQ8
LK8
M1P
M48
M7P
M~E
O5R
O5S
OK1
OVT
P2P
P6G
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
PMFND
3V.
7XB
8FD
8FK
AZQEC
DWQXO
FR3
GNUQQ
K9.
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
RC3
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c492t-fc06925f9240a25cebfbcfa963491d2c32b1b8b2cb8b9071a53ebc13a3de66ad3
IEDL.DBID M48
ISSN 1476-511X
IngestDate Wed Aug 27 01:31:58 EDT 2025
Thu Aug 21 18:36:01 EDT 2025
Thu Jul 10 22:45:55 EDT 2025
Fri Jul 25 10:56:10 EDT 2025
Tue Jun 17 22:22:58 EDT 2025
Tue Jun 10 21:15:56 EDT 2025
Tue Jul 01 00:23:20 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c492t-fc06925f9240a25cebfbcfa963491d2c32b1b8b2cb8b9071a53ebc13a3de66ad3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12944-023-01979-w
PQID 2902132906
PQPubID 42587
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_ad8be12b66944fa4b57e5e38cdcb64d3
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10694953
proquest_miscellaneous_2898313025
proquest_journals_2902132906
gale_infotracmisc_A775471933
gale_infotracacademiconefile_A775471933
crossref_primary_10_1186_s12944_023_01979_w
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-12-04
PublicationDateYYYYMMDD 2023-12-04
PublicationDate_xml – month: 12
  year: 2023
  text: 2023-12-04
  day: 04
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle Lipids in health and disease
PublicationYear 2023
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References N SeyedKhoei (1979_CR23) 2022; 21
Q Ouyang (1979_CR20) 2021; 21
Y Wei (1979_CR21) 2021; 13
L Vitek (1979_CR8) 2002; 160
L Vitek (1979_CR18) 2023; 29
L Calabresi (1979_CR32) 2010; 20
V Petrenko (1979_CR2) 2023; 91
HE Bays (1979_CR4) 2021; 5
R Kawamoto (1979_CR12) 2016; 38
J Fu (1979_CR22) 2022; 12
X Zhang (1979_CR25) 2018; 17
SH Choi (1979_CR16) 2013; 23
G Perdomo (1979_CR33) 2009; 1
M Grabacka (1979_CR27) 2016; 17
W Goessling (1979_CR34) 2000; 279
G Camejo (1979_CR28) 1988; 8
T Nakagami (1979_CR29) 1993; 1158
JC Cohen (1979_CR5) 2011; 332
L Vitek (1979_CR6) 2021; 75
N SeyedKhoei (1979_CR10) 2018; 269
S Suh (1979_CR14) 2018; 13
B Stieger (1979_CR1) 2021; 1867
K Musunuru (1979_CR3) 2010; 45
E Oda (1979_CR15) 2014; 235
DM Gordon (1979_CR26) 2019; 51
E Oda (1979_CR24) 2015; 239
JF Creeden (1979_CR17) 2021; 320
L Hou (1979_CR19) 2021; 320
N Memon (1979_CR7) 2016; 79
JP Lin (1979_CR13) 2010; 56
M Wallner (1979_CR9) 2013; 125
R Saeedi (1979_CR31) 2015; 48
E Steyrer (1979_CR30) 1988; 985
Y Wu (1979_CR11) 2011; 3
References_xml – volume: 125
  start-page: 257
  year: 2013
  ident: 1979_CR9
  publication-title: Clin Sci (Lond)
  doi: 10.1042/CS20120661
– volume: 160
  start-page: 449
  year: 2002
  ident: 1979_CR8
  publication-title: Atherosclerosis
  doi: 10.1016/S0021-9150(01)00601-3
– volume: 1158
  start-page: 189
  year: 1993
  ident: 1979_CR29
  publication-title: Biochim Biophys Acta
  doi: 10.1016/0304-4165(93)90013-X
– volume: 20
  start-page: 50
  year: 2010
  ident: 1979_CR32
  publication-title: Cardiovasc Med
– volume: 279
  start-page: G356
  year: 2000
  ident: 1979_CR34
  publication-title: Am J Physiol Gastrointest Liver Physiol
  doi: 10.1152/ajpgi.2000.279.2.G356
– volume: 51
  start-page: 234
  year: 2019
  ident: 1979_CR26
  publication-title: Physiol Genomics
  doi: 10.1152/physiolgenomics.00028.2019
– volume: 13
  start-page: 143
  year: 2021
  ident: 1979_CR21
  publication-title: Diabetol Metab Syndr
  doi: 10.1186/s13098-021-00762-0
– volume: 38
  start-page: 107
  year: 2016
  ident: 1979_CR12
  publication-title: Clin Exp Hypertens
  doi: 10.3109/10641963.2015.1060990
– volume: 12
  start-page: 792795
  year: 2022
  ident: 1979_CR22
  publication-title: Front Endocrinol (Lausanne)
  doi: 10.3389/fendo.2021.792795
– volume: 13
  start-page: e0193041
  year: 2018
  ident: 1979_CR14
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0193041
– volume: 21
  start-page: 54
  year: 2022
  ident: 1979_CR23
  publication-title: Cardiovasc Diabetol
  doi: 10.1186/s12933-022-01484-x
– volume: 21
  start-page: 373
  year: 2021
  ident: 1979_CR20
  publication-title: BMC Neurol
  doi: 10.1186/s12883-021-02398-z
– volume: 269
  start-page: 306
  year: 2018
  ident: 1979_CR10
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2017.12.021
– volume: 235
  start-page: 334
  year: 2014
  ident: 1979_CR15
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2014.05.927
– volume: 91
  start-page: 101235
  year: 2023
  ident: 1979_CR2
  publication-title: Prog Lipid Res
  doi: 10.1016/j.plipres.2023.101235
– volume: 3
  start-page: 217
  year: 2011
  ident: 1979_CR11
  publication-title: J Diabetes
  doi: 10.1111/j.1753-0407.2011.00138.x
– volume: 320
  start-page: E191
  year: 2021
  ident: 1979_CR17
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00405.2020
– volume: 1867
  start-page: 166079
  year: 2021
  ident: 1979_CR1
  publication-title: Biochim Biophys Acta Mol Basis Dis
  doi: 10.1016/j.bbadis.2021.166079
– volume: 239
  start-page: 31
  year: 2015
  ident: 1979_CR24
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2014.12.053
– volume: 56
  start-page: 1535
  year: 2010
  ident: 1979_CR13
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2010.151043
– volume: 79
  start-page: 378
  year: 2016
  ident: 1979_CR7
  publication-title: Pediatr Res
  doi: 10.1038/pr.2015.247
– volume: 8
  start-page: 368
  year: 1988
  ident: 1979_CR28
  publication-title: Arteriosclerosis
  doi: 10.1161/01.ATV.8.4.368
– volume: 320
  start-page: 112
  year: 2021
  ident: 1979_CR19
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2020.12.005
– volume: 5
  start-page: 100149
  year: 2021
  ident: 1979_CR4
  publication-title: Am J Prev Cardiol
  doi: 10.1016/j.ajpc.2021.100149
– volume: 48
  start-page: 472
  year: 2015
  ident: 1979_CR31
  publication-title: Clin Biochem
  doi: 10.1016/j.clinbiochem.2014.08.014
– volume: 17
  start-page: 217
  year: 2018
  ident: 1979_CR25
  publication-title: Lipids Health Dis
  doi: 10.1186/s12944-018-0857-7
– volume: 1
  start-page: 17
  year: 2009
  ident: 1979_CR33
  publication-title: Aging (Albany NY)
  doi: 10.18632/aging.100004
– volume: 332
  start-page: 1519
  year: 2011
  ident: 1979_CR5
  publication-title: Science
  doi: 10.1126/science.1204265
– volume: 17
  start-page: 2093
  year: 2016
  ident: 1979_CR27
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms17122093
– volume: 45
  start-page: 907
  year: 2010
  ident: 1979_CR3
  publication-title: Lipids
  doi: 10.1007/s11745-010-3408-1
– volume: 75
  start-page: 1485
  year: 2021
  ident: 1979_CR6
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2021.06.010
– volume: 29
  start-page: 315
  year: 2023
  ident: 1979_CR18
  publication-title: Trends Mol Med
  doi: 10.1016/j.molmed.2023.01.007
– volume: 23
  start-page: 31
  year: 2013
  ident: 1979_CR16
  publication-title: Nutr Metab Cardiovasc Dis
  doi: 10.1016/j.numecd.2011.03.001
– volume: 985
  start-page: 484
  year: 1988
  ident: 1979_CR30
  publication-title: Biochim Biophys Acta
  doi: 10.1016/0005-2760(88)90235-4
SSID ssj0020766
Score 2.3704636
Snippet Background Bilirubin's ability to lower lipid levels was confirmed by several studies, but those studies mainly focused on total bilirubin (TBil). The present...
Bilirubin's ability to lower lipid levels was confirmed by several studies, but those studies mainly focused on total bilirubin (TBil). The present study aimed...
BackgroundBilirubin’s ability to lower lipid levels was confirmed by several studies, but those studies mainly focused on total bilirubin (TBil). The present...
Abstract Background Bilirubin’s ability to lower lipid levels was confirmed by several studies, but those studies mainly focused on total bilirubin (TBil). The...
SourceID doaj
pubmedcentral
proquest
gale
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 1
SubjectTerms Alanine transaminase
Bilirubin
Blood lipids
Blood pressure
Body mass index
Cholesterol
Correlation analysis
Creatinine
Direct bilirubin (DBil)
Disease
Health aspects
Hemoglobin
Hyperlipidemia
Indirect bilirubin (IBil)
Laboratories
Lipids
Measurement
Metabolism
Normal distribution
Physiological aspects
Physiology
Prognosis
Risk factors
Statistical analysis
Total bilirubin (TBil)
Total cholesterol (TC)
Triglyceride (TG)
Variables
γ-Glutamyltransferase
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLghbEQqmMhOCAoq6fsY9bRFUhLScq9Wb5FYjYza42G1X998wk2aqBAxcuOcSOZHtmMvPZM58JeQ9ejemoQpG9xJIcpovgUy40QGfGQmWUweLk5Td9dS2_3qibB1d9YU7YQA88LNy5TyZkxoPWVsrKy6DKrLIwMcWgZep5PsHnHcDUCLUAnetDiYzR5y14NSkL8E8AnW1pi9uJG-rZ-v_-J_-ZJ_nA8Vw-I0_HiJEuhpE-J49yc0xOFg2g5fUd_UD7HM5-c_yYPF6OR-UnpFvWq7S6o1g_DvFkoqBr3ZpiLuyuAzhMfZNovW9pxPs5xow4ituydFVv60RXmE7U0v42IrqGMdORg7WlWHi2-7EBr0eHOkoKoo-_um37glxffvn--aoY71goorR8X1Rxri1XFcCwuecq5lCFWHkwS2lZ4lHwwIIJPMIDcDTzSuQQmfAiZa19Ei_JUbNp8itCs50nwU0yUWgZPMDuWGbDK89SJUqlZuTTYcnddqDScD0EMdoNAnIgINcLyN3OyAVK5b4n0mD3L0A53Kgc7l_KMSMfUaYOjRUkGP1YcwADRtort0D-vxJiWOh5OukJRhanzQetcKORt45bCJAE8uXPyLv7ZvwSE9eavOmgj7FG4OEwTN9MtGkys2lLU__sib4ZViVbJV7_j7V4Q55wNABMxZGn5Gi_6_JbCKj24ay3nd93ayKS
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwELZgSIgXNDYQhYGMhOABRavt2HGepoKYJqTyxKS-Wf6VEdEmXdNo2n_PXepuBCRe8hA7Spy78_mz774j5D14Naa8dFm0OabkMJU5G2KmADoz5iotNSYnz7-ri8v820Iu0oZbl8Iq93PiMFGH1uMe-SkvwRsJJCc_W19nWDUKT1dTCY2H5BFSl6FWF4t7wAUYXe0TZbQ67cC35XkGXgoAdFmU2c3IGQ2c_f_OzH9HS_7hfs4PydO0bqSznaCfkQexOSLHswYw8-qWfqBDJOewRX5EHs_Tgfkx6ef1MixvKWaRw6oyUNC4fkUxInbTAyimtgm03nbUY5WOFBdHcXOWLut1HegSg4o6OtQkoiv4ZpqYWDuK6WebqxZ8H91lU1JQAP-rX3fPyeX51x9fLrJUaSHzecm3WeWnquSyAjA2tVz66CrnKwvGmZcscC-4Y0477uECaJpZKaLzTFgRolI2iBfkoGmb-JLQWE6D4DpoL1TuLIBvX0TNK8tCJQopJ-TT_peb9Y5QwwxARCuzE5ABAZlBQOZmQj6jVO56Ihn2cKPdXJlkW8YG7SLjTil4urK5k0WUUWgfvFN5EBPyEWVq0GRBgt6mzAP4YCS_MjNkASxgJQs9T0Y9wdT8uHmvFSaZemfuFXNC3t0145MYvtbEtoc-utQCj4hh-HqkTaORjVua-udA980wN7mU4tX_3_6aPOGo2hhqk5-Qg-2mj29gwbR1bwer-A2OJhjG
  priority: 102
  providerName: ProQuest
Title Mildly elevated serum bilirubin and its correlations with lipid levels among male patients undergoing health checkups
URI https://www.proquest.com/docview/2902132906
https://www.proquest.com/docview/2898313025
https://pubmed.ncbi.nlm.nih.gov/PMC10694953
https://doaj.org/article/ad8be12b66944fa4b57e5e38cdcb64d3
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9NAEF_uA8QX0TvF6llWEH2QaHc32WweRHpyx1HoIWqhb8t-5Qy2aW0azv73zqRpMXqPviSQ3YXdnZnM_Hbng5BXoNWYdImNgokxJIfJyBofIgnQmTGbq0RhcPL4Wl5N4tE0mR6QXbmjdgOrO6Ed1pOarGbvfv3cfASB_9AIvJLvK9BZcRyB9gFgnKVZdHtIjkEzpVjRYBzvbxU4YHa5C5y5c1xHOTU5_P_9U__tPfmHOrp8SB60diQdbgn_iByE8oScDkvA0PMNfU0bz87myPyE3Bu3F-inpB4XMz_bUIwqByvTU-DAek7RQ3ZVA0impvS0WFfUYdWO1k-O4mEtnRXLwtMZOhlVtKlRROcwZ9pmZq0ohqOtbhagC-k2upICQ7gf9bJ6TCaXF98-XUVt5YXIxRlfR7kbyIwnOYCzgeGJCza3LjcgrHHGPHeCW2aV5Q4egK6ZSUSwjgkjfJDSePGEHJWLMjwlNGQDL7jyygkZWwNg3KVB8dwwn4s0SXrk7W7L9XKbYEM3wERJvSWQBgLphkD6tkfOkSr7npgcu_mwWN3oVta08coGxq2UMDo3sU3SkAShnHdWxl70yBukqUamAgo600YiwIQxGZYeYlbAFCxb6HnW6Qmi57rNO67QO87VPAOzSWAW_R55uW_GkejOVoZFDX1UpgReGcPyVYebOivrtpTF9yb9N8NY5SwRz_7HXjwn9zkKADroxGfkaL2qwwsws9a2Tw7Tadonx8Ph6OsI3ucX15-_9JtDi34jV78BPdsu7g
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGkIAXBBtohQFG4uMBRWvs2HEeECofU8fWPW3S3oy_MiratDSNqv5T_I3cpclGQOJtL32InTTO3fn8s-93R8gr8GqxdMJGwSRIyYllZI0PkQToHMc2V0IhOXl0KofnydcLcbFFfrVcGAyrbOfEeqL2M4d75AcsA2_EMTn5h_nPCKtG4elqW0JjoxbHYb0CyFa-P_oM8n3N2OGXs0_DqKkqELkkY8sod32ZMZED8OgbJlywuXW5AUVMstgzx5mNrbLMwQ8gx9gIHqyLueE-SGk8h-feIrdhWH0Ee-nFNcDrp1K2xBwlD0rwpUkSgVcEwJ6lWbTqOL-6RsC_nuDv6Mw_3N3hA3K_WafSwUaxHpKtUOyQ3UEBGH26pm9oHTlab8nvkDuj5oB-l1Sj8cRP1hRZ67CK9RQ0vJpSjMBdVADCqSk8HS9L6rAqSBOHR3EzmE7G87GnEwxiKmldA4lO4Z1pk_m1pEh3W1zOwNfSDXuTgsK5H9W8fETOb0QGj8l2MSvCHqEh63vOlFeOy8QaAPsuDYrlJvY5T4XokXftJ9fzTQIPXQMfJfVGQBoEpGsB6VWPfESpXPXE5Nv1hdniUje2rI1XNsTMSgl35yaxIg0icOW8szLxvEfeokw1ThEgQWcapgO8MCbb0gPMOpjCyhl67nd6gmm7bnOrFbqZWkp9bQg98vKqGe_EcLkizCroozLF8Ugahq862tQZWbelGH-v04vHyIXOBH_y_39_Qe4Oz0Yn-uTo9PgpucdQzTHMJ9kn28tFFZ7BYm1pn9cWQsm3mzbJ34fbVxk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mildly+elevated+serum+bilirubin+and+its+correlations+with+lipid+levels+among+male+patients+undergoing+health+checkups&rft.jtitle=Lipids+in+health+and+disease&rft.au=Xin+Bai&rft.au=Jing+Qiao&rft.au=Hong+Zhang&rft.date=2023-12-04&rft.pub=BMC&rft.eissn=1476-511X&rft.volume=22&rft.issue=1&rft.spage=1&rft.epage=8&rft_id=info:doi/10.1186%2Fs12944-023-01979-w&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_ad8be12b66944fa4b57e5e38cdcb64d3
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1476-511X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1476-511X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1476-511X&client=summon